• AztraZeneca to launch oncology drug Calquence in India expresspharma
    October 19, 2020
    AstraZeneca Pharma India has received import and market permission in Form CT-20 (Marketing Authorization- Additional Indication) from the Drugs Controller General of India for Acalabrutinib 100 mg capsules (Calquence ).
PharmaSources Customer Service